April 18, 2025

Mirco Friedrich: Forbes-List “30 Under 30 Europe”

Mirco Friedrich: Forbes-List “30 Under 30 Europe”

Mirco Julian Friedrich from the DKFZ, HI-STEM* and Heidelberg University Hospital (UKHD) was included in the renowned Forbes ‘30 Under 30 Europe’ list in the Science & Healthcare category.

The physician and cancer researcher, who has headed the Haematology and Immune Engineering junior research group since this year, initially developed successful approaches to reactivate the immune system against brain tumours.

With his current research, Friedrich aims to develop innovative strategies to reprogramme the human immune system by integrating synthetic immunology, genome editing and AI-controlled bioengineering. The aim is to prevent cancer, strengthen immune resilience and promote healthy ageing.

With this award, the US business magazine Forbes annually recognises outstanding young personalities under the age of 30 who stand out in their fields through their innovative strength, social relevance and exceptional achievements.


*The Heidelberg Institute for Stem Cell Research and Experimental Medicine (HI-STEM) gGmbH was founded in 2008 as a public-private partnership between the DKFZ and the Dietmar Hopp Foundation.

Our latest News

discover more
Diaper Recycling: Progress Even Among the Market Leader

Diaper Recycling: Progress Even Among the Market Leader

Used diapers account for a very large portion of our waste, and to date, no economically viable recycling process has been established. In the Encycling project, the NMI team led by Dr. Anne Zeck and Dr. Simon Straß developed an enzymatic process that was successfully applied to diapers from various manufacturers. Further research was needed […]

From microscopy to AI: Andreas von Deimling shaped modern brain tumor diagnostics in Heidelberg

From microscopy to AI: Andreas von Deimling shaped modern brain tumor diagnostics in Heidelberg

After almost 20 years, Professor Dr. Andreas von Deimling has handed over leadership of Neuropathology at Heidelberg University Hospital to Professor Dr. Dr. Felix Sahm. When Andreas von Deimling was appointed W3 Professor of Neuropathology in 2007, Heidelberg Faculty of Medicine at Heidelberg University, together with the German Cancer Research Center (DKFZ), pursued a strategic […]

Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany

Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany

Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany Paris and Frankfurt, October 19, 2026. Sanofi today broke ground on a new state-of-the-art insulin manufacturing facility at its BioCampus in Frankfurt, Germany. The new facility will bring a new generation of insulin production to one of Sanofi’s largest integrated research and manufacturing sites, […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp